Care for newborns exposed to substances during pregnancy
Clinical Care of Newborns with Prenatal Substance Exposure: A National Study
This study is looking at how to improve hospital care for newborns who were exposed to drugs during pregnancy, like opioids and cannabis, by finding better ways to test for substances, help with withdrawal symptoms, and support families.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11048850 on NIH RePORTER |
What this research studies
This research investigates the care practices for newborns who have been exposed to substances during pregnancy, such as opioids and cannabis. It focuses on improving hospital care by examining toxicology testing, managing withdrawal symptoms, and providing family support. The study aims to identify effective practices that can enhance the quality of care and equity for these vulnerable newborns and their families. By collaborating with the Better Outcomes through Research for Newborns (BORN) Network, the research will gather data to inform better healthcare strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include newborns who have been exposed to substances during pregnancy and their families.
Not a fit: Patients who are not newborns or who have not been exposed to substances during pregnancy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare practices that enhance the well-being of newborns exposed to substances and support their families.
How similar studies have performed: Previous research has shown that targeted interventions for substance-exposed newborns can lead to improved outcomes, indicating that this approach has potential for success.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Kair, Laura R — University of California at Davis
- Study coordinator: Kair, Laura R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.